Breast Cancer
Concure’s New $2.5M Funding to Boost Patient Access to its Radioactive Seed Treatment
[ad_1] Concure Oncology plans to use $2.5 million in new funding to help make its targeted radiation treatment option increasingly available ...Mammographic Breast Density, Microcalcifications, and Masses May be Inheritable
[ad_1] Given that these features are associated with breast cancer risk and could improve the detection of short-term risk of ...Coronavirus (COVID-19): What People With Breast Cancer Need to Know
[ad_1] Last updated: April 8, 2020 The new respiratory illness commonly referred to as “coronavirus” and officially called COVID-19 has ...Phase III ASCENT Study of Metastatic TNBC Halted Due to Compelling Efficacy
[ad_1] The decision to halt the study was based on the unanimous recommendation by an independent data safety monitoring committee ...The Changing Landscape of Targeted Breast Cancer Therapies
[ad_1] Experts provide perspective on the rapidly changing landscape of targeted therapies in breast cancer treatment, and the importance of ...Advancing the Field of Breast Cancer Care
[ad_1] ONCOLOGY® recently sat down with Joyce A. O’Shaughnessy, MD, to discuss the recent trends in breast cancer treatment and ...
